e 4031 has been researched along with Weight Reduction in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A | 1 |
| Pasam, VR | 1 |
| Thakur, RK | 1 |
| Singh, M | 1 |
| Singh, K | 1 |
| Shukla, M | 1 |
| Yadav, A | 1 |
| Dogra, S | 1 |
| Sona, C | 1 |
| Umrao, D | 1 |
| Jaiswal, S | 1 |
| Ahmad, H | 1 |
| Rashid, M | 1 |
| Singh, SK | 1 |
| Wahajuddin, M | 1 |
| Dwivedi, AK | 1 |
| Siddiqi, MI | 1 |
| Lal, J | 1 |
| Tripathi, RP | 1 |
| Yadav, PN | 1 |
1 other study available for e 4031 and Weight Reduction
| Article | Year |
|---|---|
Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Diet, High-Fat; HEK293 Cells; Histamine H3 Antagonists; | 2019 |